To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors

Peking University First Hospital, Beijing

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Cancer Hospital, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Jiangsu Province Cancer Hospital, Nanjing

The Second Hospital of Anhui Medical University, Hefei

Zhejiang Provincial Peoples Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

Chongqing Cancer Hospital, Chongqing

Hunan Cancer Hospital, Changsha

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning